Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen P Hunger

Showing results (161-170 of 346) with videos related to

Pageof 35
Sort By:
Pediatric Blood & Cancer|September 20, 2025
Caregivers' Perspectives on Changes in Family Life During B-ALL Therapy: A Qualitative Study From the Children's Oncology GroupAlexandra Dreyzin, Megan Ware, Katrina Stumbras, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2024
Reply to C.T. Matava et alSarah Alexander, John A Kairalla, Sumit Gupta, et al.
JAMA|March 2, 2021
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical TrialPatrick A Brown, Lingyun Ji, Xinxin Xu, et al.
Plos One|December 15, 2020
Assessment of the impact of inpatient infectious events in pediatric patients with newly diagnosed acute leukemia at Dr. Robert Reid Cabral Children's Hospital, Dominican RepublicJulianne E Burns, Dominga Reyes Pérez, Yimei Li, et al.
Pediatric Blood & Cancer|January 5, 2026
Diminished Quality of Life Despite Reduced Treatment in Children With B-Lymphoblastic Leukemia: Children's Oncology Group AALL0932Lyn M Balsamo, John A Kairalla, Emily Hibbitts, et al.
Haematologica|January 30, 2025
Integrated genomic analysis to reduce chromosomal analysis for the diagnosis of pediatric hematologic malignancies: addressing the shortage of cytogenetic technologistsDong Li, Sarah K Tasian, Gerald Wertheim, et al.
Blood|October 27, 2020
Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populationsWenjian Yang, Meenakshi Devidas, Yiwei Liu, et al.
British Journal of Haematology|February 13, 2003
E2A-PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical featuresRobin Foa, Antonella Vitale, Marco Mancini, et al.
Journal of the National Cancer Institute|May 13, 2022
Persistence of Chemotherapy-Induced Peripheral Neuropathy Despite Vincristine Reduction in Childhood B-Acute Lymphoblastic LeukemiaRozalyn L Rodwin, John A Kairalla, Emily Hibbitts, et al.
Cancer|December 22, 2017
Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131Wanda L Salzer, Michael J Burke, Meenakshi Devidas, et al.
Pageof 35

Showing results (161-170 of 346) with videos related to

Sort By:
Pageof 35
Pediatric Blood & Cancer|September 20, 2025
Caregivers' Perspectives on Changes in Family Life During B-ALL Therapy: A Qualitative Study From the Children's Oncology GroupAlexandra Dreyzin, Megan Ware, Katrina Stumbras, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2024
Reply to C.T. Matava et alSarah Alexander, John A Kairalla, Sumit Gupta, et al.
JAMA|March 2, 2021
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical TrialPatrick A Brown, Lingyun Ji, Xinxin Xu, et al.
Plos One|December 15, 2020
Assessment of the impact of inpatient infectious events in pediatric patients with newly diagnosed acute leukemia at Dr. Robert Reid Cabral Children's Hospital, Dominican RepublicJulianne E Burns, Dominga Reyes Pérez, Yimei Li, et al.
Pediatric Blood & Cancer|January 5, 2026
Diminished Quality of Life Despite Reduced Treatment in Children With B-Lymphoblastic Leukemia: Children's Oncology Group AALL0932Lyn M Balsamo, John A Kairalla, Emily Hibbitts, et al.
Haematologica|January 30, 2025
Integrated genomic analysis to reduce chromosomal analysis for the diagnosis of pediatric hematologic malignancies: addressing the shortage of cytogenetic technologistsDong Li, Sarah K Tasian, Gerald Wertheim, et al.
Blood|October 27, 2020
Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populationsWenjian Yang, Meenakshi Devidas, Yiwei Liu, et al.
British Journal of Haematology|February 13, 2003
E2A-PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical featuresRobin Foa, Antonella Vitale, Marco Mancini, et al.
Journal of the National Cancer Institute|May 13, 2022
Persistence of Chemotherapy-Induced Peripheral Neuropathy Despite Vincristine Reduction in Childhood B-Acute Lymphoblastic LeukemiaRozalyn L Rodwin, John A Kairalla, Emily Hibbitts, et al.
Cancer|December 22, 2017
Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131Wanda L Salzer, Michael J Burke, Meenakshi Devidas, et al.
Pageof 35